Dutch Life Sciences Conference

Pitching company River BioMedics in the spotlight

November 10, 2022

River BioMedics was founded on a novel, human iPSC-derived, 3D cardiac strip platform which represents human heart function, in an in vitro setting. The technology allows direct effects on human cardiac tissue of modification of drug target activity, to be measured at the very beginning of the drug discovery process. River exploits this in-house technology to validate novel cardiac drug discovery targets, identified from human genome wide association studies (GWAS) in heart failure.

Startups, join this Expert Class on Reimbursement for FREE

November 09, 2022

Understanding reimbursement for health and life sciences startups

“Will my device or therapy get reimbursed?” has become critical, even for early development stage life sciences companies. From early investment rounds, investors want assurance of a return on their investment, and while they may not expect start-up companies to have all the reimbursement answers, they do expect companies to have identified the correct reimbursement questions.

Partner V.O. in the spotlight: How the patent of Ceradis contributes to Green Deal.

November 09, 2022

Ceradis has a sustainable mission: to enable farmers to produce food in a way that is safer for people and better for the environment. The company develops biological alternatives to protect crops. For years, V.O. has been the strategic partner in building their patent portfolio that is critical to their commercial success.

What is digital health? Exploring the landscape and future opportunities.

November 02, 2022

Digital health is on the rise, but what is digital health exactly? In this blog post from our partner QbD, we'll explore the landscape, key technology pillars and future opportunities.

‘Digital health‘ is on the rise. It’s a term we use more and more often. But what is digital health? What does it mean? After some research, we find all kinds of definitions… It’s still a jungle out there.

Not to worry though: at the QbD Group, we strive to be at the forefront of innovation and share our latest insights and knowledge with you. In this particular blog post, we want to:

The lifesciences@work Venture Challenge Spring 2023 call opens soon

November 02, 2022

Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other researchers? Make sure you give your start-up company the best possible start by joining the lifesciences@work Venture Challenge.